184 related articles for article (PubMed ID: 21670189)
1. Simplified estimation of aminoglycoside pharmacokinetics in underweight and obese adult patients.
Pai MP; Nafziger AN; Bertino JS
Antimicrob Agents Chemother; 2011 Sep; 55(9):4006-11. PubMed ID: 21670189
[TBL] [Abstract][Full Text] [Related]
2. Assessment of aminoglycoside dosing and estimated glomerular filtration rate in determining gentamicin and tobramycin area under the curve and clearance.
Lim AK; Mathanasenarajah G; Larmour I
Intern Med J; 2015 Mar; 45(3):319-29. PubMed ID: 25581282
[TBL] [Abstract][Full Text] [Related]
3. Measurement of Skeletal Muscle Area Improves Estimation of Aminoglycoside Clearance across Body Size.
Crass RL; Ross BE; Derstine BA; Lichty M; Sullivan JA; Su GL; Wang SC; Pai MP
Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29632017
[TBL] [Abstract][Full Text] [Related]
4. Removing race and body surface area indexation for estimated kidney function based drug dosing: Aminoglycosides as justification of these principles.
Pai MP; Sitaruno S; Abdelnabi M
Pharmacotherapy; 2023 Jan; 43(1):35-42. PubMed ID: 36401789
[TBL] [Abstract][Full Text] [Related]
5. Modification of Diet in Renal Disease and modified Cockcroft-Gault formulas in predicting aminoglycoside elimination.
Bookstaver PB; Johnson JW; McCoy TP; Stewart D; Williamson JC
Ann Pharmacother; 2008 Dec; 42(12):1758-65. PubMed ID: 19047358
[TBL] [Abstract][Full Text] [Related]
6. Tobramycin Clearance Is Best Described by Renal Function Estimates in Obese and Non-obese Individuals: Results of a Prospective Rich Sampling Pharmacokinetic Study.
Smit C; Wasmann RE; Wiezer MJ; van Dongen HPA; Mouton JW; Brüggemann RJM; Knibbe CAJ
Pharm Res; 2019 May; 36(8):112. PubMed ID: 31147853
[TBL] [Abstract][Full Text] [Related]
7. The performances of the Cockcroft-Gault, modification of diet in renal disease study and chronic kidney disease epidemiology collaboration equations in predicting gentamicin clearance.
Chin PK; Florkowski CM; Begg EJ
Ann Clin Biochem; 2013 Nov; 50(Pt 6):546-57. PubMed ID: 24045301
[TBL] [Abstract][Full Text] [Related]
8. The influence of body size descriptors on the estimation of kidney function in normal weight, overweight, obese, and morbidly obese adults.
Park EJ; Pai MP; Dong T; Zhang J; Ko CW; Lawrence J; Crentsil V; Zhang L; Xu NN
Ann Pharmacother; 2012 Mar; 46(3):317-28. PubMed ID: 22395245
[TBL] [Abstract][Full Text] [Related]
9. Quantitative justification for target concentration intervention--parameter variability and predictive performance using population pharmacokinetic models for aminoglycosides.
Matthews I; Kirkpatrick C; Holford N
Br J Clin Pharmacol; 2004 Jul; 58(1):8-19. PubMed ID: 15206987
[TBL] [Abstract][Full Text] [Related]
10. Performance of the Cockcroft-Gault, MDRD, and new CKD-EPI formulas in relation to GFR, age, and body size.
Michels WM; Grootendorst DC; Verduijn M; Elliott EG; Dekker FW; Krediet RT
Clin J Am Soc Nephrol; 2010 Jun; 5(6):1003-9. PubMed ID: 20299365
[TBL] [Abstract][Full Text] [Related]
11. Exploring the Relationship between FEV
Hoff BM; Scheetz MH; Jain M; Cullina JF; Rhodes NJ
Pharmacotherapy; 2020 Jun; 40(6):584-591. PubMed ID: 32259317
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the Cockcroft-Gault, MDRD and CKD-EPI equations for estimating ganciclovir clearance.
Palacio-Lacambra ME; Comas-Reixach I; Blanco-Grau A; Suñé-Negre JM; Segarra-Medrano A; Montoro-Ronsano JB
Br J Clin Pharmacol; 2018 Sep; 84(9):2120-2128. PubMed ID: 29791023
[TBL] [Abstract][Full Text] [Related]
13. Influence of multiple courses of therapy on aminoglycoside clearance in adult patients with cystic fibrosis.
Alghanem S; Paterson I; Touw DJ; Thomson AH
J Antimicrob Chemother; 2013 Jun; 68(6):1338-47. PubMed ID: 23435691
[TBL] [Abstract][Full Text] [Related]
14. Aminoglycosides in intermittent hemodialysis: pharmacokinetics with individual dosing.
Dager WE; King JH
Ann Pharmacother; 2006 Jan; 40(1):9-14. PubMed ID: 16332944
[TBL] [Abstract][Full Text] [Related]
15. Comparison of four renal function estimation equations for pharmacokinetic modeling of gentamicin in geriatric patients.
Charhon N; Neely MN; Bourguignon L; Maire P; Jelliffe RW; Goutelle S
Antimicrob Agents Chemother; 2012 Apr; 56(4):1862-9. PubMed ID: 22290966
[TBL] [Abstract][Full Text] [Related]
16. Estimating aminoglycoside clearance and creatinine clearance in underweight patients.
Khuu T; Bagdasarian G; Leung J; Nguyen N; Lam LD; Han EE; Ambrose PJ
Am J Health Syst Pharm; 2010 Feb; 67(4):274-9. PubMed ID: 20133531
[TBL] [Abstract][Full Text] [Related]
17. Estimating the glomerular filtration rate in obese adult patients for drug dosing.
Pai MP
Adv Chronic Kidney Dis; 2010 Sep; 17(5):e53-62. PubMed ID: 20727504
[TBL] [Abstract][Full Text] [Related]
18. Experience with a once-daily dosing program of aminoglycosides in critically ill patients.
Buijk SE; Mouton JW; Gyssens IC; Verbrugh HA; Bruining HA
Intensive Care Med; 2002 Jul; 28(7):936-42. PubMed ID: 12122533
[TBL] [Abstract][Full Text] [Related]
19. Serum cystatin C for the prediction of glomerular filtration rate with regard to the dose adjustment of amikacin, gentamicin, tobramycin, and vancomycin.
Hermida J; Tutor JC
Ther Drug Monit; 2006 Jun; 28(3):326-31. PubMed ID: 16778715
[TBL] [Abstract][Full Text] [Related]
20. Aminoglycoside dosing weight correction factors for patients of various body sizes.
Traynor AM; Nafziger AN; Bertino JS
Antimicrob Agents Chemother; 1995 Feb; 39(2):545-8. PubMed ID: 7726530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
